160 related articles for article (PubMed ID: 38591958)
1. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma.
Chen X; Mohammed AF; Li C
Clin Appl Thromb Hemost; 2024; 30():10760296231221535. PubMed ID: 38591958
[TBL] [Abstract][Full Text] [Related]
2. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
Chen Y; Yang Y; Zhang XY; Fan QS; Li X; Xin YJ; Cao XJ; Wang YN; Zhou X
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1551-1560. PubMed ID: 34036405
[TBL] [Abstract][Full Text] [Related]
3. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
5. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
7. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.
Michalak A; Cichoż-Lach H; Guz M; Kozicka J; Cybulski M; Jeleniewicz W; Stepulak A
World J Gastroenterol; 2020 Dec; 26(47):7538-7549. PubMed ID: 33384553
[TBL] [Abstract][Full Text] [Related]
8. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
9. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy.
Park Y; Chang AR
Korean J Gastroenterol; 2022 Jun; 79(6):252-259. PubMed ID: 35746839
[TBL] [Abstract][Full Text] [Related]
11. Platelet Distribution Width in Hepatocellular Carcinoma.
Guo F; Zhu X; Qin X
Med Sci Monit; 2018 Apr; 24():2518-2523. PubMed ID: 29689031
[TBL] [Abstract][Full Text] [Related]
12. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
Schobert IT; Savic LJ; Chapiro J; Bousabarah K; Chen E; Laage-Gaupp F; Tefera J; Nezami N; Lin M; Pollak J; Schlachter T
Eur Radiol; 2020 Oct; 30(10):5663-5673. PubMed ID: 32424595
[TBL] [Abstract][Full Text] [Related]
15. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
Yang YT; Jiang JH; Yang HJ; Wu ZJ; Xiao ZM; Xiang BD
Sci Rep; 2018 Feb; 8(1):2535. PubMed ID: 29416061
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis.
Zhu X; Zhou H
J Hepatocell Carcinoma; 2022; 9():1127-1136. PubMed ID: 36338430
[TBL] [Abstract][Full Text] [Related]
17. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism.
Telo S; Kuluöztürk M; Deveci F; Kirkil G
Int Angiol; 2019 Feb; 38(1):4-9. PubMed ID: 30618227
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X
BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of hepatocellular carcinoma: A single-center study.
Quiros-Roldan E; Properzi M; Amadasi S; Raffetti E; Ferraresi A; Biasi L; Focà E; Castelli F
J Med Virol; 2019 Feb; 91(2):241-248. PubMed ID: 30216474
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of inflammation-based score in patients with hepatocellular carcinoma after liver transplantation.
Kong W; Qu E; Sheng N; Zhang J; Li X; Zheng J; Gao Y
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e282-e289. PubMed ID: 33405420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
